VITAMIN K ANTAGONISTS VS. DIRECT ORAL ANTICOAGULANTS IN STROKE RISK AMONG ATRIAL FIBRILLATION PATIENTS WITH END-STAGE RENAL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引:0
|
作者
Soliman, Y. [1 ]
Mouffokes, A. [2 ]
Amer, B. [3 ]
El-Samahy, M. [4 ]
Al-Dardery, N. [5 ]
Umar, T. [6 ]
Al-Manaseer, B. [7 ]
Arar, A. [8 ]
Hukamdad, M. [9 ]
Abdelazeem, B. [10 ]
机构
[1] Assiut Univ, Fac Med, Assiut, Egypt
[2] Univ Oran I Ahmed Ben Bella, Fac Med, Bir El Djir, Algeria
[3] Benha Univ, Fac Med, Banha, Egypt
[4] Zagazig Univ Egypt, Fac Med, Zagazig, Egypt
[5] Fayoum Univ, Fac Med, Al Fayyum, Egypt
[6] UCL, Div Surg & Intervent Sci, Fac Med Sci, London, England
[7] Univ Jordan, Sch Med, Amman, Jordan
[8] Univ Galway Ireland, Coll Med Nursing & Hlth Sci, Galway, Ireland
[9] Univ Illinois, Coll Med, Chicago, IL USA
[10] West Virginia Univ, Dept Cardiol, Morgantown, WV USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
SO070 / #
引用
收藏
页码:89 / 89
页数:1
相关论文
共 50 条
  • [21] Severe Bleeding Risk of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Stroke Prevention and Treatment in Patients with Atrial Fibrillation: A Systematic Review and Network Meta-Analysis
    Wenlin Xu
    Meina Lv
    Shuyi Wu
    Shaojun Jiang
    Zhiwei Zeng
    Zongwei Fang
    Jiafen Qian
    Mingrong Chen
    Jiana Chen
    Jinhua Zhang
    Cardiovascular Drugs and Therapy, 2023, 37 : 363 - 377
  • [22] Effects of direct oral anticoagulants vs. vitamin K antagonists on acute kidney injury in patients with atrial fibrillation: A systematic review
    Ren, Chengfa
    Zhao, Yudan
    Liu, Dehui
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [23] Effectiveness and safety of direct oral anticoagulants in atrial fibrillation patients switched from vitamin K antagonists: A systematic review and meta-analysis
    Hellfritzsch, Maja
    Adelborg, Kasper
    Damkier, Per
    Johnsen, Soren Paaske
    Hallas, Jesper
    Pottegard, Anton
    Grove, Erik Lerkevang
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 126 (01) : 21 - 31
  • [24] Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis
    Mariani, Marco Valerio
    Magnocavallo, Michele
    Straito, Martina
    Piro, Agostino
    Severino, Paolo
    Iannucci, Gino
    Chimenti, Cristina
    Mancone, Massimo
    Della Rocca, Domenico Giovanni
    Forleo, Giovanni Battista
    Fedele, Francesco
    Lavalle, Carlo
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 51 (02) : 419 - 429
  • [25] Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis
    Marco Valerio Mariani
    Michele Magnocavallo
    Martina Straito
    Agostino Piro
    Paolo Severino
    Gino Iannucci
    Cristina Chimenti
    Massimo Mancone
    Domenico Giovanni Della Rocca
    Giovanni Battista Forleo
    Francesco Fedele
    Carlo Lavalle
    Journal of Thrombosis and Thrombolysis, 2021, 51 : 419 - 429
  • [26] Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation
    Andreas Zirlik
    Christoph Bode
    Journal of Thrombosis and Thrombolysis, 2017, 43 : 365 - 379
  • [27] Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation
    Zirlik, Andreas
    Bode, Christoph
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2017, 43 (03) : 365 - 379
  • [28] Oral Anticoagulants in Patients With Atrial Fibrillation and End-Stage Renal Disease
    Zaman, Junaid A. B.
    Bhandari, Anil K.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2019, 24 (06) : 499 - 508
  • [29] Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic review and meta-analysis
    Noviyani, Rini
    Youngkong, Sitaporn
    Nathisuwan, Surakit
    Bagepally, Bhavani Shankara
    Chaikledkaew, Usa
    Chaiyakunapruk, Nathorn
    McKay, Gareth
    Sritara, Piyamitr
    Attia, John
    Thakkinstian, Ammarin
    BMJ EVIDENCE-BASED MEDICINE, 2022, 27 (04) : 215 - 223
  • [30] Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and End-Stage Renal Disease
    Nishimura, Marin
    Hsu, Jonathan C.
    AMERICAN JOURNAL OF CARDIOLOGY, 2018, 121 (01): : 131 - 140